Current role of liquid biopsy in metastatic breast cancer and future perspectives

被引：0

作者：

Polasik, Arkadius ^{[1
]}

Friedl, Thomas W. P. ^{[1
]}

Schramm, Amelie ^{[1
]}

Schochter, Fabienne ^{[1
]}

Huober, Jens ^{[1
]}

Rack, Brigitte ^{[2
]}

Trapp, Elisabeth ^{[2
]}

Tzschaschel, Marie ^{[2
]}

Fasching, Peter A. ^{[3
]}

Taran, Florin-Andrei ^{[4
]}

Hartkopf, Andreas ^{[4
]}

Schneeweiss, Andreas ^{[5
,6
]}

Mueller, Volkmar ^{[7
]}

Aktas, Bahriye ^{[8
]}

Pantel, Klaus ^{[9
]}

Janni, Wolfgang ^{[1
]}

Fehm, Tanja ^{[10
]}

机构：

[1] Univ Hosp Ulm, Gynecol & Obstet, Prittwitzstr 43, D-89075 Ulm, Germany

[2] Klinikum Ludwig Maximilians Univ, Gynecol & Obstet, Munich, Germany

[3] Univ Hosp Erlangen, Gynecol & Obstet, Erlangen, Germany

[4] Univ Hosp Tubingen, Gynecol & Obstet, Tubingen, Germany

[5] Univ Hosp Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany

[6] Univ Hosp Heidelberg, Dept Gynecol & Obstet, Heidelberg, Germany

[7] Univ Hosp Hamburg Eppendorf, Gynecol & Obstet, Hamburg, Germany

[8] Univ Hosp Essen, Gynecol & Obstet, Essen, Germany

[9] Univ Hosp Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany

[10] Heinrich Heine Univ, Gynecol & Obstet, Dusseldorf, Germany

来源：

GYNAKOLOGE | 2016年 / 49卷 / 09期

关键词：

Survival; Quality of life; Biopsy; Circulating tumor cells; Disease progression;

D O I：

10.1007/s00129-016-3929-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The possibility of tumor dissemination via the blood systemhas been known for many years. Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) are detectable in the peripheral blood of patients with early as well as metastatic breast cancer. The prognostic relevance of these biomarkers has already been described. Repeated blood sampling along the course of disease enables CTCs and ctDNA to be monitored in terms of a regular "liquid biopsy". Combined with an additional molecular analysis, this might be helpful in gaining information about tumor characteristics, tumor heterogeneity, and possible therapy resistance based on these factors, without the necessity of an invasive core biopsy. The assessment of molecular attributesmay be indispensable for obtaining an optimized and personalized therapy aimed at extended survival and/or improved quality of life. This review summarizes current knowledge and describes possible future perspectives for the treatment of metastasized breast cancer.

引用

页码：680 / 684

页数：5

共 50 条

[31] Liquid Biopsy in Breast Cancer [J].

Tay, Timothy Kwang Yong ;

Tan, Puay Hoon .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) :678-686

[32] Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives [J].

Bayne, Christopher E. ;

Williams, Stephen B. ;

Cooperberg, Matthew R. ;

Gleave, Martin E. ;

Graefen, Markus ;

Montorsi, Francesco ;

Novara, Giacomo ;

Smaldone, Marc C. ;

Sooriakumaran, Prasanna ;

Wiklund, Peter N. ;

Chapin, Brian F. .

EUROPEAN UROLOGY, 2016, 69 (05) :775-787

[33] Locally advanced breast cancer in Brazil: current status and future perspectives [J].

Werutsky, Gustavo ;

Nunesm, Paulo ;

Barrios, Carlos .

ECANCERMEDICALSCIENCE, 2019, 13

[34] The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios [J].

Normanno, Nicola ;

Cervantes, Andres ;

Ciardiello, Fortunato ;

De Luca, Antonella ;

Pinto, Carmine .

CANCER TREATMENT REVIEWS, 2018, 70 :1-8

[35] Liquid biopsy in the clinical management of bladder cancer: current status and future developments [J].

Kouba, Erik ;

Lopez-Beltran, Antonio ;

Montironi, Rodolfo ;

Massari, Francesco ;

Huang, Kun ;

Santoni, Matteo ;

Chovanec, Michal ;

Cheng, Michael ;

Scarpelli, Marina ;

Zhang, Jie ;

Cimadamore, Alessia ;

Cheng, Liang .

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (02) :255-264

[36] Role of Liquid Biopsy in Clinical Decision-Making for Breast Cancer [J].

Carolyn Hall ;

Vanessa Sarli ;

Salyna Meas ;

Anthony Lucci .

Current Breast Cancer Reports, 2019, 11 :52-66

[37] New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to Precision Medicine [J].

Alberca-del Arco, Fernardo ;

Prieto-Cuadra, Daniel ;

Santos-Perez de la Blanca, Rocio ;

Saez-Barranquero, Felipe ;

Matas-Rico, Elisa ;

Herrera-Imbroda, Bernardo .

CANCERS, 2024, 16 (04)

[38] Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools [J].

Gerratana, Lorenzo ;

Davis, Andrew A. ;

Polano, Maurizio ;

Zhang, Qiang ;

Shah, Ami N. ;

Lin, Chenyu ;

Basile, Debora ;

Toffoli, Giuseppe ;

Wehbe, Firas ;

Puglisi, Fabio ;

Behdad, Amir ;

Platanias, Leonidas C. ;

Gradishar, William J. ;

Cristofanilli, Massimo .

EUROPEAN JOURNAL OF CANCER, 2021, 143 :147-157

[39] The Present and Future of Clinical Management in Metastatic Breast Cancer [J].

Lin, Pauline H. ;

Laliotis, George .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)

[40] Immunotherapy for Metastatic Triple Negative Breast Cancer: Current Paradigm and Future Approaches [J].

Geurts, Veerle ;

Kok, Marleen .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (06) :628-643

← 1 2 3 4 5 →